The Pennant Group, Inc. — Cyborg Score 7/10

Strong
Healthcare Services - Home Health, Hospice & Senior Living

Strategic Profile

Spun off from The Ensign Group in 2019 to focus on non-skilled nursing healthcare services, Pennant operates across 13 western and midwestern states serving patients of all ages including seniors. Over the last five years, The Pennant Group grew its sales at an impressive 19.8% compounded annual growth rate, beating the average healthcare company.

Cyborg Score Rationale

Recent Q4 2025 results showed revenue up 53.3% year-on-year to $289.3 million, with full-year guidance around $1.15 billion and non-GAAP EPS of $0.34 beating estimates by 7.7%. Operating margins expanded to 6%, up 1.1 percentage points year-on-year, showing improving operational efficiency. Growth dynamics remain solid despite regulatory headwinds in healthcare.

Top Insights

  • Annualized revenue growth of 32.9% over the last two years is above its five-year trend, suggesting accelerating demand.
  • Admissions reached 28,941 in Q4 with 12.5% year-on-year growth, lower than revenue growth, indicating the company benefited from price increases.
  • Analysts expect revenue to grow 22.4% over the next 12 months, a deceleration versus recent years but still commendable.
  • Demographic tailwinds and healthcare delivery shifts favor growth through organic expansion and acquisitions, with operational efficiencies enhancing margins and profitability.

Named Competitors

  • Home Health & Senior Living Services — Parent company from which Pennant was spun off; operates similar home health and senior living segments
  • Home Healthcare Platform — Provider of home health and non-medical home care services
  • Hospice & Home Health — Focused provider of home health and hospice services
  • Physical Therapy Services — Rehabilitation and physical therapy services provider

Recent Developments

  • (February 2026) Q4 2025 earnings call scheduled for February 26, 2026
  • (February 2026) Full year 2025 revenue reached approximately $1.15 billion with record-breaking performance across all segments
  • (September 2025) Muir Home Health joint venture announced to boost revenue and market share

Open the full interactive The Pennant Group, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →